Gabapentin attenuates superior oblique myokymia.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11992881.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate therapeutic effects of oral gabapentin therapy on superior oblique myokymia. Observational case series with measurement of visual acuity and eye movements before, during, and after therapy. Two adult patients with superior oblique myokymia, refractory to other therapies, were treated with gabapentin orally after informed consent was obtained. Eye movements were measured using the magnetic search coil technique. Superior oblique myokymia completely resolved after starting gabapentin. Gabapentin may be an effective treatment for superior oblique myokymia; a double-blind study seems justified.
Medical subject headings
- Acetates
- Amines
- Cyclohexanecarboxylic Acids
- Diplopia
- Excitatory Amino Acid Antagonists
- Trochlear Nerve Diseases
- gamma-Aminobutyric Acid